✦ LIBER ✦

Immunologic and molecular evaluation of residual disease in b-cell chronic lymphocytic leukemia patients in clinical remission phase

✍ Scribed by Maura Brugiatelli; Vincenzo Callea; Fortunato Morabito; Bianca Oliva; Paola Francia Di Celle; Maria Teresa Fierro; Alberto Neri; Robin Foa

Publisher: John Wiley and Sons
Year: 1989
Tongue: English
Weight: 550 KB
Volume: 63
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19890515)63:10<1979::aid-cncr2820631018>3.0.co;2-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical and molecular predictors of dis

Clinical and molecular predictors of disease severity and survival in chronic lymphocytic leukemia

✍ J. Brice Weinberg; Alicia D. Volkheimer; Youwei Chen; Bethany E. Beasley; Ning J 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB 👁 2 views

Arthritis of the knees in b cell chronic

Arthritis of the knees in b cell chronic lymphocytic leukemia: a patient with immunologic evidence of b lymphocytic synovial infiltration

✍ Frédéric Gagnerie; Bruno Taillan; Liana Euller-Ziegler; Jean Kermarec; Francisqu 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB 👁 2 views

Correlation of clinical data with proteo

Correlation of clinical data with proteomics profiles in 24 patients with B-cell chronic lymphocytic leukemia

✍ Tilman Voss; Horst Ahorn; Peter Haberl; Hartmut Döhner; Klaus Wilgenbus 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 116 KB 👁 2 views

Molecular and transcriptional characteri

Molecular and transcriptional characterization of 17p loss in B-cell chronic lymphocytic leukemia

✍ Sonia Fabris; Laura Mosca; Katia Todoerti; Giovanna Cutrona; Marta Lionetti; Dan 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 960 KB

## Abstract Distinct genetic abnormalities, such as __TP53__ deletion at 17p13.1, have been identified as having adverse prognostic relevance in B‐cell chronic lymphocytic leukemia (B‐CLL), and conventional cytogenetic studies have shown that __TP53__ deletion in B‐CLL is mainly associated with the

Cell-mediated immune responsiveness of p

Cell-mediated immune responsiveness of patients with acute lymphocytic leukemia in remission

✍ Dr. Robert K. Oldham; Roy S. Weiner; Georges Mathé; Jacqueline Breard; Marie-Chr 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 French ⚖ 985 KB

## Abstract Children with acute lymphocytic leukemia (ALL) in remission and undergoing either chemotherapy or immunotherapy were tested for general cell‐mediated immunocompetence and cell‐mediated reactivity to tumor‐associated antigens (TAA) using the following parameters: skin tests with recall a

Consolidation and maintenance immunother

Consolidation and maintenance immunotherapy with rituximab improve clinical outcome in patients with B-cell chronic lymphocytic leukemia

✍ Giovanni Del Poeta; Maria Ilaria Del Principe; Francesco Buccisano; Luca Maurill 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB 👁 1 views

## Abstract ## BACKGROUND. Rituximab in sequential combination with fludarabine (Flu) allowed patients with B‐cell chronic lymphocytic leukemia (B‐CLL) to achieve higher remission rates and longer response duration. Based on their recent experience in indolent non‐Hodgkin lymphomas, in this study,